M. D. Anderson Cancer Center - News Releases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Test helps target glioblastoma patients most likely to benefit from bevacizumab
A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin®), according to new research from The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 4, 2013 Category: Cancer & Oncology Source Type: news

Bevacizumab offers no benefit for newly diagnosed glioblastoma, MD Anderson-led study finds
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 4, 2013 Category: Cancer & Oncology Source Type: news

MET protein levels show promise as biomarker for aggressive colon cancer
MET protein levels correlate strongly with epithelial-mesenchymal transition (EMT) phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - June 4, 2013 Category: Cancer & Oncology Source Type: news

American Cancer Society honors Isaiah J. Fidler for outstanding research
When Isaiah J. Fidler, D.V.M., Ph.D., left his veterinary surgical practice to pursue a doctorate that would allow him to study and combat the lethal spread of cancer to other organs, he got lots of advice.  The common message: Don't go there. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 30, 2013 Category: Cancer & Oncology Source Type: news

Colleen Villamin claims $15,000 nurse-oncologist prize
Colleen Villamin, BSN, of The University of Texas MD Anderson Cancer Center, is the recipient of the 2013 Ethel Fleming Arceneaux Outstanding Nurse-Oncologist Award. Established by The Brown Foundation, Inc. in 1982, the award is the institution's highest nursing honor. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 28, 2013 Category: Cancer & Oncology Source Type: news

Lyda Hill commits $50 million to Moon Shots Program
Lyda Hill, of Dallas, has pledged $50 million to The University of Texas MD Anderson Cancer Center's Moon Shots Program, an unprecedented, comprehensive assault on cancer announced in September 2012. Hill's transformational gift is the largest single private philanthropic contribution to date in support of this ambitious effort to dramatically reduce cancer deaths (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - May 21, 2013 Category: Cancer & Oncology Source Type: news